REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 117 filers reported holding REVOLUTION MEDICINES INC in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,756,988 | +227.2% | 63,475 | +181.5% | 0.01% | +333.3% |
| Q4 2022 | $537,046 | -26.1% | 22,546 | -38.9% | 0.00% | -25.0% |
| Q3 2022 | $727,000 | -59.8% | 36,883 | -60.3% | 0.00% | -63.6% |
| Q2 2022 | $1,809,000 | +59.2% | 92,838 | +108.4% | 0.01% | +10.0% |
| Q1 2022 | $1,136,000 | -35.6% | 44,546 | -36.4% | 0.01% | -41.2% |
| Q4 2021 | $1,764,000 | +99.1% | 70,083 | +117.6% | 0.02% | +54.5% |
| Q3 2021 | $886,000 | -63.3% | 32,210 | -57.7% | 0.01% | -59.3% |
| Q2 2021 | $2,416,000 | +56.3% | 76,106 | +125.9% | 0.03% | +35.0% |
| Q1 2021 | $1,546,000 | – | 33,691 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |